Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 1/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | KDM1A | O60341 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5351739 | 1.00 | DRD2 (0.58) | DRD2CYP2C9MAPTALDH1A1LMNA | |
| SCHEMBL8045452 | 0.95 | DRD2 (0.54) | DRD2CYP2C9MAPTALDH1A1LMNA | |
| SCHEMBL7903735 | 0.95 | DRD2 (0.54) | DRD2CYP2C9MAPTALDH1A1LMNA | |
| SCHEMBL8045462 | 0.95 | DRD2 (0.54) | DRD2CYP2C9MAPTALDH1A1LMNA | |
| SCHEMBL9258676 | 0.95 | DRD2 (0.54) | DRD2CYP2C9MAPTALDH1A1LMNA | |
| SCHEMBL9258683 | 0.95 | DRD2 (0.54) | DRD2CYP2C9MAPTALDH1A1LMNA | |
| SCHEMBL21456800 | 0.92 | DRD2 (0.51) | DRD2CYP2C9MAPTALDH1A1LMNA | |
| SCHEMBL5343187 | 0.91 | DRD2 (0.50) | DRD2CYP2C9MAPTALDH1A1LMNA | |
| SCHEMBL13621706 | 0.91 | DRD2 (0.50) | DRD2CYP2C9MAPTALDH1A1LMNA | |
| SCHEMBL8368584 | 0.90 | DRD2 (0.55) | DRD2CYP2C9MAPTALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119555817-A | Pretreatment method for efficiently extracting trace liquid crystal monomer from water based on membrane filtration technology | 南京理工大学 | 2025-03-04 | — | — | CN | claimed |
| CN-119555817-A | Pretreatment method for efficiently extracting trace liquid crystal monomer from water based on membrane filtration technology | 南京理工大学 | 2025-03-04 | — | — | CN | disclosed |
| US-7186447-B2 | Two plane parallel support plates with frame form cell, with integrated non-linear elements for switching individual picture elements on support plates, and nematic liquid crystal mixture is present in cell, having positive dielectric anisotropy and high resistivity | MERCK PATENT GMBH (DE) | 2007-03-06 | — | — | US | disclosed |
| US-7045176-B2 | Liquid crystal composition having high-speed response property and liquid crystal display using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2006-05-16 | — | — | US | disclosed |
| US-6905740-B2 | The invention relates to a matrix liquid crystal display containing integrated non-linear elements and a liquid crystal mixture which has a particularly high resistivity. | MERCK PATENT GMBH (DE) | 2005-06-14 | — | — | US | disclosed |
| EP-1501830-A1 | 7-ARYL-3,9-DIAZABICYCLO[3.3.1]NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES | Actelion Pharmaceuticals Ltd. (CH) | 2005-02-02 | — | — | EP | disclosed |
| US-20040119051-A1 | Liquid crystal composition having high-speed response property and liquid crystal display using the same | SAMSUNG ELECTRONICS CO., LTD. | 2004-06-24 | — | — | US | disclosed |
| WO-2003093267-A1 | 7-ARYL-3,9-DIAZABICYCLO(3.3.1)NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES | ACTELION PHARMACEUTICALS LTD (CH) | 2003-11-13 | — | — | WO | disclosed |
| US-20030207046-A1 | Matrix liquid crystal display | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2003-11-06 | — | — | US | disclosed |
| US-6562419-B1 | Matrix liquid crystal display | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2003-05-13 | — | — | US | disclosed |
| EP-0155317-B1 | LIQUID CRYSTAL MIXTURES AND NEW ANISOTROPIC COMPOUNDS THEREFOR | MERCK PATENT GmbH (DE) | 1987-07-08 | — | — | EP | disclosed |
| EP-0226592-A1 | LIQUID CRYSTAL PHASE. | MERCK PATENT GMBH (DE) | 1987-07-01 | — | — | EP | disclosed |
| EP-0215800-A1 | PYRIMIDINES. | MERCK PATENT GMBH (DE) | 1987-04-01 | — | — | EP | disclosed |
| WO-1986005799-A1 | LIQUID CRYSTAL PHASE | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1986-10-09 | — | — | WO | disclosed |
| WO-1986004060-A1 | PYRIMIDINES | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1986-07-17 | — | — | WO | disclosed |
| EP-0158252-A2 | Liquid crystal phase | MERCK PATENT GmbH (DE) | 1985-10-16 | — | — | EP | disclosed |
| EP-0155317-A1 | LIQUID CRYSTAL MIXTURES AND NEW ANISOTROPIC COMPOUNDS THEREFOR. | MERCK PATENT GMBH (DE) | 1985-09-25 | — | — | EP | disclosed |
| EP-0151446-A2 | Liquid crystal phase | MERCK PATENT GmbH (DE) | 1985-08-14 | — | — | EP | disclosed |
| WO-1985001295-A1 | LIQUID CRYSTAL MIXTURES AND NEW ANISOTROPIC COMPOUNDS THEREFOR | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1985-03-28 | — | — | WO | disclosed |
| EP-0118061-A2 | Liquid crystal guest host systems | MERCK PATENT GmbH (DE) | 1984-09-12 | — | — | EP | disclosed |